Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FXUK0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,870
Award facts
- Contract value 100% obligated
- $11,870.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 16, 2026, valued at $11,870.48 for the supply of Eliquis 5 mg tablets (60-count). This firm fixed-price contract, funded by the Defense Logistics Agency (DLA), a component of the Department of Defense, represents a non-set-aside, competitively awarded transaction. The place of performance is established in Conshohocken, Pennsylvania, with an ultimate completion date of January 20, 2026. This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly operating under the AmerSourceBergen name), which holds the parent indefinite delivery contract with DLA. The company supplies a broad range of pharmaceutical products and medical commodities to support federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and Department of Veterans Affairs. This award reflects the company's critical role in the federal medical supply chain and its demonstrated capability to fulfill competitive procurement requirements for essential pharmaceutical products across multiple therapeutic domains at both small and substantial order volumes.
Quick answers
Who was awarded contract SPE2DR26FXUK0?
SPE2DR26FXUK0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FXUK0 worth?
The government has obligated $11,870 on SPE2DR26FXUK0.
Is contract SPE2DR26FXUK0 an order under another contract?
Yes. SPE2DR26FXUK0 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUK0 competed?
The extent of competition for SPE2DR26FXUK0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award